X
Please Wait
Applying Filters...
01 SANOFI AVENTIS US (3)
01 TABLET;ORAL (3)
01 RX (3)
01 ARAVA (3)
01 Yes (3)
Iran Expo
Not Confirmed
Contact SupplierIran Expo
Not Confirmed
Contact SupplierIran Expo
Not Confirmed
Contact Supplier19
Sanofi, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
One of their notable products is LEFLUNOMIDE, with a corresponding application number 20905.
Regulatory Information RX
With a dosage strength 100MG
Dosage Form Route TABLET; ORAL
Reference Listed Drug Yes
Approved since 1998-09-10
18
Sanofi, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
One of their notable products is LEFLUNOMIDE, with a corresponding application number 20905.
Regulatory Information RX
With a dosage strength 10MG
Dosage Form Route TABLET; ORAL
Reference Listed Drug Yes
Approved since 1998-09-10
Therapeutic Equivalence (TE) Code AB
17
Sanofi, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
One of their notable products is LEFLUNOMIDE, with a corresponding application number 20905.
Regulatory Information RX
With a dosage strength 20MG
Dosage Form Route TABLET; ORAL
Reference Listed Drug Yes
Approved since 1998-09-10
Therapeutic Equivalence (TE) Code AB
Market Place
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
